Qiming Healthcare
Venture capitalBellevue · 5 people tracked
Find your way into Qiming Healthcare
Fund manager profile
Qiming Healthcare is a venture fund manager based in Bellevue. SEC filings show 3 venture funds on record, most recently Qiming U.S. Healthcare Fund III, L.P. ($300M offering) filed April 2021.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 5 people
from public directoriesWhat they invest in
from 8 of 10 portfolio companiesBiotech ×6Healthtech ×2Deep Tech ×1Medical Devices ×1
HQs:United States×10
Investments · 10 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12022 · 12021 · 12020 · 12019 · 22018 · 22016 · 110 dated
HealthtechMenlo Park, US
Thomas G. Wiggans(Executive Officer, Director)inEugene A. Bauer(Executive Officer, Director)Andrew Guggenhime(Executive Officer)Luis Pena(Executive Officer)Christopher Griffith(Executive Officer)
BoardFred Craves(Director)in
Board seatMark D. McDadeMark McDade· per SEC Form D · $1M raise · filed Dec 2018
Co-investorsAisling CapitalBay City CapitalCanaan PartnersForesite CapitalNew Enterprise Associates (NEA)Fidelity Investments+1 more
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)Michael Ross(Director)
Board seatMark McDade· per SEC Form D · $66.6M raise · filed Nov 2025
Co-investorsQiming Venture PartnersSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming Venture Partners USA
BiotechSeattle, US
Charles Richardson(Senior Vice President, Technical Operations)Adam K. Simpson(President and Chief Executive Officer)Niranjan Kanesa-thasan(Chief Medical Officer)Douglas A. Holtzman(Chief Scientific Officer and Secretary)Cassia Cearley(Treasurer, Chief Business Officer)
BoardPeter Kolchinsky(Director)in
Board seatMark McDade· per SEC Form D · $51M raise · filed Oct 2019
Co-investorsRA CapitalSanofi Ventures
BiotechChestnut Hill, US
Joseph Italiano(Director)inJonathan Thon(Director)Sven Erik Karlsson(Executive Officer)Peter Finn(Executive Officer)
Board seatMark McDade· per SEC Form D
Co-investorsBoston Harbor AngelsThird Rock VenturesVivo Capital
WindMIL Therapeutics is a clinical-stage biotechnology company developing cell-based immuno-oncology therapies using marrow-infiltrating lymphocytes (MILs), T cells extracted from a cancer patient's bone marrow that are activated and expanded before being returned to the patient.
BiotechMedical DevicesPrinceton, US
Ivan Borrello(Founder)Kimberly Noonan(Founder)in
BoardBrian Halak(Executive Officer, Director)
Board seatAnna FrenchMark McDade· per SEC Form D · $5M raise · filed Feb 2021
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Allergen ResearchAmphivena TherapeuticsBoulder Care, Inc.Soda Health, Inc.Talaris Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesFrequently asked questions
- Where is Qiming Healthcare located?
- Qiming Healthcare is headquartered in Bellevue, US.